|
||||||
|
 | |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
|
Gene: ENSG00000143412 |
Summary for ANXA9 |
 Gene summary |
| Gene information | Ensembl ID | ENSG00000143412 | Gene symbol | ANXA9 |
| Gene name | annexin A9 | |
| HGNC | 547 | |
| Entrez ID | 8416 | |
| Gene type | protein_coding | |
| Synonyms | ANXA9| | |
| UniProtAcc | O76027 |
| Drugs associated with this gene(DrugBank). |
| Gene ID | Gene Symbol | Drug ID | Drug Name | Drug Type |
| Cancer therapeutic drugs associated with this gene(NCI). |
| Gene ID | Gene Name | Drug ID | Drug Name | Drug Type | Cancer |
Top |
Structure and expression level for ANXA9 |
| AS events and RNA A-to-I editing events of the gene in TCGA based on Genvode V22 structure. ∗For more information on exon skipping events please check the ExonskipDB database. ∗For more information on exon skipping events please check the CAeditome database. |
 |
| Landscape of gene expressions across multiple cancer types. |
 |
| Differentially expressed gene analysis between tumor male and tumor female samples. |
| Coding Name | Base Mean | log2FoldChange | lfcSE | Stat | P value | P.adjust Value | Cancer Type |
| Differentially expressed gene analysis between tumor male and normal male samples. |
 |
| Coding Name | Base Mean | log2FoldChange | lfcSE | Stat | P value | P.adjust Value | Cancer Type |
| ANXA9 | 1.66e+03 | 1.70e+00 | 5.11e-01 | 3.31e+00 | 9.18e-04 | 3.08e-03 | BLCA |
| Differentially expressed gene analysis between tumor female and normal female samples. |
 |
| Coding Name | Base Mean | log2FoldChange | lfcSE | Stat | P value | P.adjust Value | Cancer Type |
| ANXA9 | 2.37e+03 | 1.72e+00 | 1.25e-01 | 1.37e+01 | 7.45e-43 | 5.96e-42 | BRCA |
Top |
Sex-biased somatic mutation for ANXA9 |
| ∗For more information on exon skipping events please check the ExonskipDB database. |
| Gene ID | Cancer Type | Hugo Symbol | Male | Female | pval | or | ci.up | ci.low | adjPval |
Top |
DNA methylation with beta values for ANXA9 |
| Landscape of DNA methylation across multiple cancer types. |
 |
| Differentially expressed CpG sites between male tumor and female tumor patients. |
| Cancer Type | CpG Site | Position | CpG Island | Position to Gene | ave1 | ave2 | wilcoxon.w | wilcoxon.p | padj | dBeta |
| BRCA | cg20437604 | chr1:150982078 | CGI:chr1:150974020-150975474 | UTR,promoter,exon,gene body | 3.43e-01 | 2.17e-01 | 2.96e+00 | 3.10e-03 | 1.67e-02 | 1.26e-01 |
| KIRP | cg04144222 | chr1:150981237 | CGI:chr1:150974020-150975474 | promoter | 7.46e-01 | 8.69e-01 | -5.58e+00 | 2.39e-08 | 2.87e-07 | -1.23e-01 |
| KIRP | cg07337598 | chr1:150981467 | CGI:chr1:150974020-150975474 | promoter | 7.64e-01 | 8.78e-01 | -4.80e+00 | 1.60e-06 | 1.70e-05 | -1.13e-01 |
| DLBC | cg20437604 | chr1:150982078 | CGI:chr1:150974020-150975474 | UTR,promoter,exon,gene body | 5.77e-01 | 7.16e-01 | -2.09e+00 | 3.66e-02 | 4.54e-02 | -1.39e-01 |
| Differentially expressed CpG sites between male tumor and male normal patients. |
| Cancer Type | CpG Site | Position | CpG Island | Position to Gene | ave1 | ave2 | wilcoxon.w | wilcoxon.p | padj | dBeta |
| THCA | cg04144222 | chr1:150981237 | CGI:chr1:150974020-150975474 | promoter | 7.07e-01 | 5.66e-01 | 3.78e+00 | 1.58e-04 | 8.27e-04 | 1.40e-01 |
| HNSC | cg25468058 | chr1:150981204 | CGI:chr1:150974020-150975474 | promoter | 7.72e-01 | 8.98e-01 | -3.45e+00 | 5.51e-04 | 1.09e-03 | -1.26e-01 |
| HNSC | cg04144222 | chr1:150981237 | CGI:chr1:150974020-150975474 | promoter | 6.93e-01 | 8.21e-01 | -3.28e+00 | 1.04e-03 | 1.88e-03 | -1.29e-01 |
| HNSC | cg07337598 | chr1:150981467 | CGI:chr1:150974020-150975474 | promoter | 5.51e-01 | 6.81e-01 | -3.06e+00 | 2.21e-03 | 3.56e-03 | -1.30e-01 |
| LUSC | cg07337598 | chr1:150981467 | CGI:chr1:150974020-150975474 | promoter | 5.51e-01 | 7.66e-01 | -3.80e+00 | 1.44e-04 | 8.22e-04 | -2.16e-01 |
| COAD | cg07337598 | chr1:150981467 | CGI:chr1:150974020-150975474 | promoter | 3.96e-01 | 5.32e-01 | -3.52e+00 | 4.33e-04 | 1.14e-03 | -1.36e-01 |
| COAD | cg20437604 | chr1:150982078 | CGI:chr1:150974020-150975474 | UTR,promoter,exon,gene body | 3.17e-01 | 4.49e-01 | -3.91e+00 | 9.40e-05 | 3.34e-04 | -1.32e-01 |
| COAD | cg13320146 | chr1:150982350 | CGI:chr1:150974020-150975474 | UTR,promoter,exon,gene body | 2.52e-01 | 3.76e-01 | -4.10e+00 | 4.15e-05 | 1.75e-04 | -1.24e-01 |
| LIHC | cg07337598 | chr1:150981467 | CGI:chr1:150974020-150975474 | promoter | 3.99e-01 | 5.12e-01 | -4.50e+00 | 6.69e-06 | 1.93e-05 | -1.13e-01 |
| KIRP | cg07337598 | chr1:150981467 | CGI:chr1:150974020-150975474 | promoter | 8.78e-01 | 7.64e-01 | 5.24e+00 | 1.61e-07 | 1.23e-06 | 1.14e-01 |
| CHOL | cg25468058 | chr1:150981204 | CGI:chr1:150974020-150975474 | promoter | 4.84e-01 | 6.80e-01 | -2.58e+00 | 9.87e-03 | 2.15e-02 | -1.96e-01 |
| CHOL | cg04144222 | chr1:150981237 | CGI:chr1:150974020-150975474 | promoter | 4.47e-01 | 5.80e-01 | -2.29e+00 | 2.23e-02 | 3.24e-02 | -1.34e-01 |
| Differentially expressed CpG sites between female tumor and female normal patients. |
| Cancer Type | CpG Site | Position | CpG Island | Position to Gene | ave1 | ave2 | wilcoxon.w | wilcoxon.p | padj | dBeta |
| BRCA | cg25468058 | chr1:150981204 | CGI:chr1:150974020-150975474 | promoter | 6.61e-01 | 8.83e-01 | -1.11e+01 | 9.34e-29 | 1.17e-27 | -2.22e-01 |
| BRCA | cg04144222 | chr1:150981237 | CGI:chr1:150974020-150975474 | promoter | 5.98e-01 | 8.18e-01 | -1.11e+01 | 7.18e-29 | 9.15e-28 | -2.20e-01 |
| BRCA | cg07337598 | chr1:150981467 | CGI:chr1:150974020-150975474 | promoter | 5.20e-01 | 8.23e-01 | -1.34e+01 | 1.00e-40 | 9.43e-39 | -3.03e-01 |
| BRCA | cg20437604 | chr1:150982078 | CGI:chr1:150974020-150975474 | UTR,promoter,exon,gene body | 3.43e-01 | 4.97e-01 | -9.22e+00 | 3.09e-20 | 1.70e-19 | -1.54e-01 |
| BRCA | cg13320146 | chr1:150982350 | CGI:chr1:150974020-150975474 | UTR,promoter,exon,gene body | 2.61e-01 | 3.85e-01 | -7.92e+00 | 2.42e-15 | 9.04e-15 | -1.24e-01 |
| LUAD | cg13320146 | chr1:150982350 | CGI:chr1:150974020-150975474 | UTR,promoter,exon,gene body | 4.08e-01 | 5.50e-01 | -2.96e+00 | 3.05e-03 | 6.81e-03 | -1.41e-01 |
Top |
Exon skipping events with PSI in TCGA for ANXA9 |
| ∗Please access ExonSkipDB for exon skipping annotation. |
| Landscape of exon skipping events across multiple cancer types. |
 |
| Differentially expressed exon skipping events between male tumor and female tumor patients. |
| Cancer Type | Exon Skipping | ave.female_T | ave.female_N | wilcoxon.w | wilcoxon.p | padj | dPSI |
| Differentially expressed exon skipping events between male tumor and male normal patients. |
| Cancer Type | Exon Skipping | ave.female_T | ave.female_N | wilcoxon.w | wilcoxon.p | padj | dPSI |
| Differentially expressed exon skipping events between female tumor and female normal patients. |
| Cancer Type | Exon Skipping | ave.female_T | ave.female_N | wilcoxon.w | wilcoxon.p | padj | dPSI |
Top |
RNA A-to-I editing events in TCGA for ANXA9 |
| ∗Please access CAeditome for RNA editing annotation. |
| Differentially expressed RNA editing events between male tumor and female tumor patients. |
| Cancer Type | Transcript | Editing | ave.male_T | ave.female_T | wilcoxon.w | wilcoxon.p | p_adj | dFre |
| Differentially expressed RNA editing events between male tumor and male normal patients. |
| Cancer Type | Transcript | Editing | ave.male_T | ave.female_T | wilcoxon.w | wilcoxon.p | p_adj | dFre |
| Differentially expressed RNA editing events between female tumor and female normal patients. |
| Cancer Type | Transcript | Editing | ave.male_T | ave.female_T | wilcoxon.w | wilcoxon.p | p_adj | dFre |
| Protein coding RNA editing(s). |
| Editing Position | Variant Type | Gene Symbol | Transcript ID | NTchange | AAchange |
Top |
Sex-biased TF-Gene network for ANXA9 |
| TFs related to ANXA9. ∗The female-biased TF-gene edges were identified if Female_Edge_threshold>0.98 and Male_Edge_threshold<=0.98. ∗The male-biased TF-gene edges were identified if Male_Edge_threshold>0.98 and Female_Edge_threshold<=0.98. |
 |
| Cancer Type | TF | Target Gene | Male Edge Score | Male Edge Threshold | Female Edge Score | Female Edge Threshold | Type |
| ACC | PRDM6 | ANXA9 | 3.63e+00 | 1.03e-02 | 4.46e+00 | 9.84e-01 | Female-biased |
| ESCA | GLIS3 | ANXA9 | 4.61e+00 | 9.87e-01 | 3.85e+00 | 7.91e-03 | Male-biased |
| ESCA | GTF3A | ANXA9 | 4.01e+00 | 9.86e-01 | 3.03e+00 | 2.21e-03 | Male-biased |
| ESCA | HIC1 | ANXA9 | 4.51e+00 | 9.87e-01 | 3.75e+00 | 7.87e-03 | Male-biased |
| ESCA | MSANTD3 | ANXA9 | 4.58e+00 | 9.84e-01 | 3.88e+00 | 1.14e-02 | Male-biased |
| ESCA | NHLH1 | ANXA9 | 4.01e+00 | 9.82e-01 | 3.20e+00 | 5.61e-03 | Male-biased |
| ESCA | TFAP2A | ANXA9 | 3.98e+00 | 9.84e-01 | 3.08e+00 | 3.63e-03 | Male-biased |
| ESCA | TFAP2B | ANXA9 | 4.28e+00 | 9.90e-01 | 3.29e+00 | 2.15e-03 | Male-biased |
| ESCA | TFAP2C | ANXA9 | 4.15e+00 | 9.86e-01 | 3.29e+00 | 4.26e-03 | Male-biased |
| ESCA | ZNF254 | ANXA9 | 4.31e+00 | 9.81e-01 | 3.61e+00 | 1.12e-02 | Male-biased |
| ESCA | ZSCAN1 | ANXA9 | 4.12e+00 | 9.87e-01 | 3.20e+00 | 3.12e-03 | Male-biased |
| GBM | ASCL1 | ANXA9 | 2.22e+00 | 1.23e-03 | 4.06e+00 | 9.86e-01 | Female-biased |
| GBM | GLIS3 | ANXA9 | 3.63e+00 | 5.06e-03 | 4.96e+00 | 9.92e-01 | Female-biased |
| GBM | GTF3A | ANXA9 | 2.68e+00 | 2.26e-03 | 4.31e+00 | 9.90e-01 | Female-biased |
| GBM | HIC1 | ANXA9 | 3.35e+00 | 4.80e-03 | 4.70e+00 | 9.91e-01 | Female-biased |
| GBM | MSANTD3 | ANXA9 | 3.53e+00 | 5.14e-03 | 4.86e+00 | 9.91e-01 | Female-biased |
| GBM | NHLH1 | ANXA9 | 2.58e+00 | 2.37e-03 | 4.18e+00 | 9.87e-01 | Female-biased |
| GBM | NR1I3 | ANXA9 | 3.49e+00 | 8.96e-03 | 4.59e+00 | 9.86e-01 | Female-biased |
| GBM | RBAK | ANXA9 | 2.17e+00 | 1.52e-03 | 3.93e+00 | 9.82e-01 | Female-biased |
| GBM | TCF12 | ANXA9 | 2.27e+00 | 1.18e-03 | 4.12e+00 | 9.87e-01 | Female-biased |
| GBM | TFAP2A | ANXA9 | 2.44e+00 | 1.24e-03 | 4.28e+00 | 9.90e-01 | Female-biased |
| GBM | TFAP2B | ANXA9 | 2.56e+00 | 1.08e-03 | 4.46e+00 | 9.93e-01 | Female-biased |
| GBM | TFAP2C | ANXA9 | 2.58e+00 | 1.39e-03 | 4.38e+00 | 9.92e-01 | Female-biased |
| GBM | ZBTB6 | ANXA9 | 3.48e+00 | 6.25e-03 | 4.72e+00 | 9.90e-01 | Female-biased |
| GBM | ZFP14 | ANXA9 | 2.40e+00 | 1.56e-03 | 4.15e+00 | 9.88e-01 | Female-biased |
| GBM | ZNF189 | ANXA9 | 2.43e+00 | 1.62e-03 | 4.17e+00 | 9.88e-01 | Female-biased |
| GBM | ZNF197 | ANXA9 | 2.91e+00 | 6.66e-03 | 4.12e+00 | 9.81e-01 | Female-biased |
| GBM | ZNF254 | ANXA9 | 3.19e+00 | 5.81e-03 | 4.46e+00 | 9.88e-01 | Female-biased |
| GBM | ZNF28 | ANXA9 | 1.94e+00 | 2.66e-04 | 4.25e+00 | 9.91e-01 | Female-biased |
| GBM | ZNF322 | ANXA9 | 2.46e+00 | 1.43e-03 | 4.25e+00 | 9.90e-01 | Female-biased |
| GBM | ZNF415 | ANXA9 | 2.55e+00 | 1.53e-03 | 4.31e+00 | 9.91e-01 | Female-biased |
| GBM | ZNF419 | ANXA9 | 2.89e+00 | 3.76e-03 | 4.33e+00 | 9.88e-01 | Female-biased |
| GBM | ZNF468 | ANXA9 | 2.10e+00 | 1.11e-03 | 3.98e+00 | 9.84e-01 | Female-biased |
| GBM | ZNF483 | ANXA9 | 2.79e+00 | 2.38e-03 | 4.39e+00 | 9.91e-01 | Female-biased |
| GBM | ZNF548 | ANXA9 | 2.19e+00 | 1.28e-03 | 4.02e+00 | 9.85e-01 | Female-biased |
| GBM | ZNF596 | ANXA9 | 2.40e+00 | 2.73e-03 | 3.94e+00 | 9.80e-01 | Female-biased |
| GBM | ZNF707 | ANXA9 | 2.70e+00 | 1.57e-03 | 4.46e+00 | 9.92e-01 | Female-biased |
| GBM | ZNF749 | ANXA9 | 3.46e+00 | 7.39e-03 | 4.64e+00 | 9.88e-01 | Female-biased |
| GBM | ZNF776 | ANXA9 | 2.34e+00 | 7.96e-04 | 4.34e+00 | 9.92e-01 | Female-biased |
| GBM | ZNF799 | ANXA9 | 3.92e+00 | 1.62e-02 | 4.80e+00 | 9.80e-01 | Female-biased |
| GBM | ZNF816 | ANXA9 | 2.19e+00 | 7.56e-04 | 4.20e+00 | 9.90e-01 | Female-biased |
| GBM | ZNF860 | ANXA9 | 2.19e+00 | 7.81e-04 | 4.19e+00 | 9.89e-01 | Female-biased |
| GBM | ZSCAN1 | ANXA9 | 3.11e+00 | 4.73e-03 | 4.46e+00 | 9.89e-01 | Female-biased |
| GBM | ZSCAN22 | ANXA9 | 2.15e+00 | 1.12e-03 | 4.03e+00 | 9.85e-01 | Female-biased |
| GBM | ZSCAN30 | ANXA9 | 2.05e+00 | 7.67e-04 | 4.05e+00 | 9.86e-01 | Female-biased |
| GBM | ZSCAN5 | ANXA9 | 3.19e+00 | 5.31e-03 | 4.49e+00 | 9.89e-01 | Female-biased |
| LAML | ASCL1 | ANXA9 | 2.87e+00 | 3.00e-03 | 4.07e+00 | 9.81e-01 | Female-biased |
| LAML | GLIS3 | ANXA9 | 3.98e+00 | 1.21e-02 | 4.83e+00 | 9.83e-01 | Female-biased |
| LAML | HIC1 | ANXA9 | 3.71e+00 | 8.70e-03 | 4.64e+00 | 9.84e-01 | Female-biased |
| LAML | MSANTD3 | ANXA9 | 3.73e+00 | 6.46e-03 | 4.74e+00 | 9.88e-01 | Female-biased |
| LAML | NHLH1 | ANXA9 | 3.08e+00 | 2.01e-03 | 4.38e+00 | 9.88e-01 | Female-biased |
| LAML | TCF12 | ANXA9 | 2.80e+00 | 1.97e-03 | 4.10e+00 | 9.83e-01 | Female-biased |
| LAML | TFAP2A | ANXA9 | 3.18e+00 | 3.84e-03 | 4.32e+00 | 9.85e-01 | Female-biased |
| LAML | TFAP2B | ANXA9 | 3.33e+00 | 3.98e-03 | 4.47e+00 | 9.87e-01 | Female-biased |
| LAML | TFAP2C | ANXA9 | 3.32e+00 | 4.58e-03 | 4.42e+00 | 9.86e-01 | Female-biased |
| LAML | ZBTB6 | ANXA9 | 3.88e+00 | 1.27e-02 | 4.71e+00 | 9.81e-01 | Female-biased |
| LAML | ZFP14 | ANXA9 | 3.08e+00 | 2.66e-03 | 4.31e+00 | 9.86e-01 | Female-biased |
| LAML | ZNF28 | ANXA9 | 3.08e+00 | 3.21e-03 | 4.27e+00 | 9.85e-01 | Female-biased |
| LAML | ZNF322 | ANXA9 | 3.06e+00 | 2.94e-03 | 4.26e+00 | 9.85e-01 | Female-biased |
| LAML | ZNF415 | ANXA9 | 3.15e+00 | 3.18e-03 | 4.34e+00 | 9.86e-01 | Female-biased |
| LAML | ZNF419 | ANXA9 | 3.49e+00 | 6.12e-03 | 4.52e+00 | 9.86e-01 | Female-biased |
| LAML | ZNF483 | ANXA9 | 3.21e+00 | 4.16e-03 | 4.33e+00 | 9.85e-01 | Female-biased |
| LAML | ZNF707 | ANXA9 | 3.47e+00 | 3.11e-03 | 4.68e+00 | 9.90e-01 | Female-biased |
| LAML | ZNF816 | ANXA9 | 3.11e+00 | 2.77e-03 | 4.34e+00 | 9.86e-01 | Female-biased |
| LAML | ZNF860 | ANXA9 | 3.04e+00 | 3.19e-03 | 4.23e+00 | 9.84e-01 | Female-biased |
| MESO | ZNF85 | ANXA9 | 4.00e+00 | 9.51e-03 | 5.30e+00 | 9.88e-01 | Female-biased |
| PCPG | ZNF548 | ANXA9 | 2.75e+00 | 2.13e-03 | 3.89e+00 | 9.81e-01 | Female-biased |
| SARC | HKR1 | ANXA9 | 2.47e+00 | 8.45e-05 | 4.01e+00 | 9.86e-01 | Female-biased |
| SARC | KLF15 | ANXA9 | 2.80e+00 | 7.68e-04 | 3.91e+00 | 9.82e-01 | Female-biased |
| SARC | KLF16 | ANXA9 | 2.60e+00 | 1.49e-04 | 4.03e+00 | 9.86e-01 | Female-biased |
| SARC | VEZF1 | ANXA9 | 3.03e+00 | 1.74e-03 | 3.99e+00 | 9.83e-01 | Female-biased |
| SARC | WT1 | ANXA9 | 2.76e+00 | 7.06e-04 | 3.88e+00 | 9.81e-01 | Female-biased |
| SARC | ZBTB17 | ANXA9 | 3.22e+00 | 1.17e-03 | 4.26e+00 | 9.90e-01 | Female-biased |
| SARC | ZNF132 | ANXA9 | 2.68e+00 | 4.04e-04 | 3.92e+00 | 9.83e-01 | Female-biased |
| SARC | ZNF180 | ANXA9 | 2.88e+00 | 2.92e-04 | 4.19e+00 | 9.89e-01 | Female-biased |
| SARC | ZNF263 | ANXA9 | 2.94e+00 | 1.72e-03 | 3.90e+00 | 9.81e-01 | Female-biased |
| SARC | ZNF341 | ANXA9 | 2.92e+00 | 5.35e-04 | 4.11e+00 | 9.87e-01 | Female-biased |
| SARC | ZNF383 | ANXA9 | 2.65e+00 | 2.54e-04 | 3.98e+00 | 9.85e-01 | Female-biased |
| SARC | ZNF432 | ANXA9 | 3.20e+00 | 1.40e-03 | 4.20e+00 | 9.88e-01 | Female-biased |
| SARC | ZNF468 | ANXA9 | 2.34e+00 | 9.50e-05 | 3.86e+00 | 9.81e-01 | Female-biased |
| SARC | ZNF529 | ANXA9 | 2.57e+00 | 9.91e-05 | 4.09e+00 | 9.87e-01 | Female-biased |
| SARC | ZNF548 | ANXA9 | 2.60e+00 | 7.89e-05 | 4.15e+00 | 9.89e-01 | Female-biased |
| SARC | ZNF774 | ANXA9 | 3.53e+00 | 2.50e-03 | 4.43e+00 | 9.90e-01 | Female-biased |
| SARC | ZNF776 | ANXA9 | 2.67e+00 | 2.76e-04 | 3.98e+00 | 9.85e-01 | Female-biased |
| SARC | ZNF880 | ANXA9 | 3.02e+00 | 9.04e-04 | 4.10e+00 | 9.87e-01 | Female-biased |
| SARC | ZNF93 | ANXA9 | 2.43e+00 | 1.11e-04 | 3.92e+00 | 9.83e-01 | Female-biased |
| SARC | ZSCAN22 | ANXA9 | 2.37e+00 | 8.96e-05 | 3.90e+00 | 9.83e-01 | Female-biased |
| ANXA9 related gene. ∗Only the gene encode TF might with this result. ∗For more information please check Sex-biased TF-Coding gene network. |
Top |
Sex-biased RBP-ES network for ANXA9 |
| RBPs related to ES in ANXA9. ∗The female-biased RBP-ES edges were identified if Female_Edge_threshold>0.98 and Male_Edge_threshold<=0.98. ∗The male-biased RBP-ES edges were identified if Male_Edge_threshold>0.98 and Female_Edge_threshold<=0.98. |
 |
| Cancer Type | RBP | Target ES | Male Edge Score | Male Edge Threshold | Female Edge Score | Female Edge Threshold | Type |
| LIHC | SAMD4A | exon_skip_9902 | 8.66e+00 | 9.90e-01 | 8.13e+00 | 3.58e-03 | Male-biased |
| ANXA9 related ES. ∗Only the gene encode RBP might with this result. ∗For more information please check Sex-biased RBP-ES network in cancer. |
Top |
Sex-biased CeRNA regulation of gene |
| Sex-biased CeRNA regulation of gene. |
| Gene ID | ceRNA(lncRNA-miRNA-mRNA) | Group | Cancer Type |
Top |
Sex-biased eQTL regulation of gene |
| Sex-biased eQTL regulation of gene (The figures only show the pairs with FDR <1e-5. For more information please check the below table). |
| eQTL | Description |
| Male-specific eQTL regulation. |
| SNP ID | SNP Info | Position to Gene | Effect Score | FDR | Cancer Type | Biased Type |
| rs11239952 | chr1:147243554:A:G | - | -0.0576048986249442 | 0.0127437402398905 | LUAD | Female-baised eQTL |
| rs10900331 | chr1:147261471:G:C | - | -0.054853816023574 | 0.0180474477203262 | LUAD | Female-baised eQTL |
| Female-specific eQTL regulation. |
| SNP ID | SNP Info | Position to Gene | Effect Score | FDR | Cancer Type | Biased Type |
| rs2297760 | chr1:152514558:T:C | - | 0.148935913409747 | 0.00839645996408578 | LIHC | Male-baised eQTL |
| rs35392872 | chr1:150575462:G:A | - | 0.0924131636600632 | 0.0395707117918473 | LUAD | Male-baised eQTL |
| rs35118879 | chr1:150628204:C:A | - | 0.0922292334888775 | 0.0404484873127957 | LUAD | Male-baised eQTL |
| rs822506 | chr1:155877029:A:G | - | -0.100446569533937 | 0.000867662218126821 | COAD | Male-baised eQTL |
| rs11804747 | chr1:158881730:T:C | - | 0.0511886983185965 | 0.0157109165237246 | COAD | Male-baised eQTL |
| rs60387547 | chr1:147114957:T:C | - | 0.0486626585645781 | 0.0161177437592565 | COAD | Male-baised eQTL |
| rs148250410 | chr1:158889528:C:T | - | 0.0523389638984736 | 0.0168334211348127 | COAD | Male-baised eQTL |
| rs74839845 | chr1:158889660:C:A | - | 0.0523389638984736 | 0.0168334211348127 | COAD | Male-baised eQTL |
| rs2000938 | chr1:158880566:G:T | - | 0.0508033456196805 | 0.0174290653456243 | COAD | Male-baised eQTL |
| rs2156788 | chr1:158895316:C:T | - | 0.0512023891037383 | 0.0183836645272746 | COAD | Male-baised eQTL |
| rs2820182 | chr1:158865475:C:G | - | 0.0525305336330748 | 0.0231589095694814 | COAD | Male-baised eQTL |
| rs55722226 | chr1:158865817:C:T | - | 0.0499102205700759 | 0.0276238256975537 | COAD | Male-baised eQTL |
| rs2820180 | chr1:158866378:C:G | - | 0.0499102205700759 | 0.0276238256975537 | COAD | Male-baised eQTL |
| rs2820125 | chr1:158865049:C:T | - | 0.0498385288329985 | 0.0283656641156438 | COAD | Male-baised eQTL |
| rs2820183 | chr1:158865434:A:G | - | 0.0498385288329985 | 0.0283656641156438 | COAD | Male-baised eQTL |
| rs2518498 | chr1:158865441:T:C | - | 0.0498385288329985 | 0.0283656641156438 | COAD | Male-baised eQTL |
| rs2262415 | chr1:158865528:C:T | - | 0.0498385288329985 | 0.0283656641156438 | COAD | Male-baised eQTL |
| rs144370071 | chr1:158865543:T:C | - | 0.0498385288329985 | 0.0283656641156438 | COAD | Male-baised eQTL |
| rs2262417 | chr1:158865655:T:G | - | 0.0498385288329985 | 0.0283656641156438 | COAD | Male-baised eQTL |
| rs2262418 | chr1:158865713:T:G | - | 0.0498385288329985 | 0.0283656641156438 | COAD | Male-baised eQTL |
| rs2852707 | chr1:158871470:T:C | - | 0.0495325108376861 | 0.0294349231050153 | COAD | Male-baised eQTL |
| rs2852706 | chr1:158866776:C:T | - | 0.0494983304395944 | 0.0306351373875992 | COAD | Male-baised eQTL |
| rs2518499 | chr1:158866911:T:C | - | 0.0477955858057809 | 0.0367955187917164 | COAD | Male-baised eQTL |
| rs2518501 | chr1:158867612:G:A | - | 0.0477955858057809 | 0.0367955187917164 | COAD | Male-baised eQTL |
| rs138407511 | chr1:158867850:A:G | - | 0.0477955858057809 | 0.0367955187917164 | COAD | Male-baised eQTL |
| rs138728555 | chr1:158868279:A:T | - | 0.0477955858057809 | 0.0367955187917164 | COAD | Male-baised eQTL |
| rs115440086 | chr1:158868394:T:C | - | 0.0477955858057809 | 0.0367955187917164 | COAD | Male-baised eQTL |
| rs115454054 | chr1:158868435:A:T | - | 0.0477955858057809 | 0.0367955187917164 | COAD | Male-baised eQTL |
| rs116821150 | chr1:158868441:C:T | - | 0.0477955858057809 | 0.0367955187917164 | COAD | Male-baised eQTL |
| rs144739151 | chr1:158868571:C:T | - | 0.0477955858057809 | 0.0367955187917164 | COAD | Male-baised eQTL |
| rs3133242 | chr1:158868843:G:C | - | 0.0477955858057809 | 0.0367955187917164 | COAD | Male-baised eQTL |
| rs2427812 | chr1:158869302:C:A | - | 0.0477955858057809 | 0.0367955187917164 | COAD | Male-baised eQTL |
| rs2494038 | chr1:158869435:A:G | - | 0.0477955858057809 | 0.0367955187917164 | COAD | Male-baised eQTL |
| rs12132721 | chr1:158869557:T:C | - | 0.0477955858057809 | 0.0367955187917164 | COAD | Male-baised eQTL |
| rs145659826 | chr1:158869653:C:T | - | 0.0477955858057809 | 0.0367955187917164 | COAD | Male-baised eQTL |
| rs2820178 | chr1:158869916:A:G | - | 0.0477955858057809 | 0.0367955187917164 | COAD | Male-baised eQTL |
| rs2518503 | chr1:158869996:C:T | - | 0.0477955858057809 | 0.0367955187917164 | COAD | Male-baised eQTL |
| rs2820177 | chr1:158870035:C:A | - | 0.0477955858057809 | 0.0367955187917164 | COAD | Male-baised eQTL |
| rs4657464 | chr1:158870101:C:G | - | 0.0477955858057809 | 0.0367955187917164 | COAD | Male-baised eQTL |
| rs4657465 | chr1:158870189:T:C | - | 0.0477955858057809 | 0.0367955187917164 | COAD | Male-baised eQTL |
| rs2518504 | chr1:158870394:C:G | - | 0.0477955858057809 | 0.0367955187917164 | COAD | Male-baised eQTL |
| rs2820176 | chr1:158870414:G:A | - | 0.0477955858057809 | 0.0367955187917164 | COAD | Male-baised eQTL |
| rs2820175 | chr1:158870585:C:A | - | 0.0477955858057809 | 0.0367955187917164 | COAD | Male-baised eQTL |
| rs2518505 | chr1:158870697:T:C | - | 0.0477955858057809 | 0.0367955187917164 | COAD | Male-baised eQTL |
| rs2820173 | chr1:158872294:A:G | - | 0.047881378652586 | 0.0368678910548641 | COAD | Male-baised eQTL |
| rs2494072 | chr1:158872347:T:C | - | 0.047881378652586 | 0.0368678910548641 | COAD | Male-baised eQTL |
| rs4999244 | chr1:158872549:T:C | - | 0.047881378652586 | 0.0368678910548641 | COAD | Male-baised eQTL |
| rs4999243 | chr1:158872570:T:C | - | 0.047881378652586 | 0.0368678910548641 | COAD | Male-baised eQTL |
| rs4999242 | chr1:158872571:A:C | - | 0.047881378652586 | 0.0368678910548641 | COAD | Male-baised eQTL |
| rs4999241 | chr1:158872609:T:C | - | 0.047881378652586 | 0.0368678910548641 | COAD | Male-baised eQTL |
| rs2518506 | chr1:158871339:C:T | - | 0.0477263510212878 | 0.0368861459743961 | COAD | Male-baised eQTL |
| rs2820174 | chr1:158871682:A:G | - | 0.0477263510212878 | 0.0368861459743961 | COAD | Male-baised eQTL |
| rs2518508 | chr1:158871754:C:T | - | 0.0477263510212878 | 0.0368861459743961 | COAD | Male-baised eQTL |
| rs2852708 | chr1:158871902:T:C | - | 0.0477263510212878 | 0.0368861459743961 | COAD | Male-baised eQTL |
| rs2518509 | chr1:158871915:G:A | - | 0.0477263510212878 | 0.0368861459743961 | COAD | Male-baised eQTL |
| rs2518510 | chr1:158872230:C:T | - | 0.0477263510212878 | 0.0368861459743961 | COAD | Male-baised eQTL |
| rs2518512 | chr1:158872778:C:T | - | 0.0477263510212878 | 0.0368861459743961 | COAD | Male-baised eQTL |
| rs2820172 | chr1:158872781:A:G | - | 0.0477263510212878 | 0.0368861459743961 | COAD | Male-baised eQTL |
| rs2820171 | chr1:158872818:G:A | - | 0.0477263510212878 | 0.0368861459743961 | COAD | Male-baised eQTL |
| rs2820170 | chr1:158872963:G:A | - | 0.0477263510212878 | 0.0368861459743961 | COAD | Male-baised eQTL |
| rs2518513 | chr1:158873042:T:G | - | 0.0477263510212878 | 0.0368861459743961 | COAD | Male-baised eQTL |
| rs2518514 | chr1:158873109:A:G | - | 0.0477263510212878 | 0.0368861459743961 | COAD | Male-baised eQTL |
| rs2820169 | chr1:158873112:C:T | - | 0.0477263510212878 | 0.0368861459743961 | COAD | Male-baised eQTL |
| rs949400 | chr1:158873424:A:T | - | 0.0477263510212878 | 0.0368861459743961 | COAD | Male-baised eQTL |
| rs949401 | chr1:158873788:C:T | - | 0.0477263510212878 | 0.0368861459743961 | COAD | Male-baised eQTL |
| rs2494037 | chr1:158870902:T:C | - | 0.0504762778108112 | 0.037486860826285 | COAD | Male-baised eQTL |
| rs2494036 | chr1:158870927:A:G | - | 0.0504762778108112 | 0.037486860826285 | COAD | Male-baised eQTL |
| rs2427813 | chr1:158870949:C:T | - | 0.0504762778108112 | 0.037486860826285 | COAD | Male-baised eQTL |
| Opposite sex-biased eQTL regulation. |
| SNP ID | SNP Info | Position to Gene | Male Effect | Male FDR | Female Effect | Female FDR | Sex-biased Gene in Cancer | Cancer Type |
Top |
Sex-biased eQTM regulation of gene |
| Sex-biased eQTM regulation of gene (The figures only show the pairs with FDR<1e-5. For more information please check the below table). |
| eQTM | Description |
 | Gene ID: ENSG00000143412 |
| CpG Site: cg20437604 | |
| Position to Gene: gene,exon,promoter,UTR | |
| Male Effect: -0.074511255621829 | |
| Female Effect: - | |
 | Gene ID: ENSG00000143412 |
| CpG Site: cg20437604 | |
| Position to Gene: gene,exon,promoter,UTR | |
| Male Effect: - | |
| Female Effect: -0.315476345471923 | |
 | Gene ID: ENSG00000143412 |
| CpG Site: cg07337598 | |
| Position to Gene: promoter | |
| Male Effect: - | |
| Female Effect: -0.250066029328995 |
| Male-specific eQTM regulation. |
| CpG Site | CpG Postion | Position to Gene | Effect Score | FDR | Cor.r | Cor.Pvalue | Cancer Type |
| cg20437604 | chr1:150982078 | gene,exon,promoter,UTR | -0.074511255621829 | 8.82837933151193e-05 | -0.38416837810766535 | 2.970331962065433e-07 | COAD |
| Female-specific eQTM regulation. |
| CpG Site | CpG Postion | Position to Gene | Effect Score | FDR | Cor.r | Cor.Pvalue | Cancer Type |
| cg20437604 | chr1:150982078 | gene,exon,promoter,UTR | -0.315476345471923 | 5.5736788956122e-21 | -0.5836739260554079 | 1.1133078880357235e-24 | LUAD |
| cg07337598 | chr1:150981467 | promoter | -0.250066029328995 | 1.18348217634508e-11 | -0.4602473265462451 | 8.982996573336568e-15 | LUAD |
| Opposite sex-biased eQTM regulation. |
| CpG Site | CpG Postion | CpG Island | Position to Gene | Male Effect | Male FDR | Female Effect | Female FDR | Male Cor | Male P-value | Female Cor | Female P-value | Sex-biased Coding Gene | Cancer Type |
Top |
Sex-biased sQTL regulation of gene |
| Sex-biased sQTL regulation of gene (The figures only show the pairs with FDR <1e-5. For more information please check the below table). |
| sQTL | Description |
| Male-specific sQTL regulation. |
| ES ID | Skipped Exon | ORF Anno | SNP ID | SNP Info | SNP Position to ES | Effect Score | FDR | Cancer Type | Biased Type |
| Female-specific sQTL regulation. |
| ES ID | Skipped Exon | ORF Anno | SNP ID | SNP Info | SNP Position to ES | Effect Score | FDR | Cancer Type | Biased Type |
| Opposite sex-biased sQTL regulation. |
| ES ID | Skipped Exon | ORF Anno | SNP ID | SNP Info | SNP Position to ES | Male Effect | Male FDR | Female Effect | Female FDR | Cancer Type |
Top |
Sex-biased sQTM regulation of gene |
| Sex-biased sQTM regulation of gene (The figures only show the pairs with FDR <1e-5. For more information please check the below table). |
| sQTM | Description |
| Male-specific sQTM regulation. |
| EX ID | Skipped Exon | CPG Site | CPG Position | Position to EX Events | Effect Score | FDR | Cor.r | Cor.Pvalue | ORF_anno | Cancer Type |
| Female-specific sQTM regulation. |
| EX ID | Skipped Exon | CPG Site | CPG Position | Position to EX Events | Effect Score | FDR | Cor.r | Cor.Pvalue | ORF_anno | Cancer Type |
| Opposite sex-biased sQTM regulation. |
| EX ID | EX Info | Skipped Exon | CPG Site | CPG Position | CPG Island | Position to EX Events | Male Effect | Male FDR | Female Effect | Female FDR | Male Correlation | Male P-value | Female Correlation | Female P-value | ORF_anno | Cancer Type |
Top |
Related disease information of ANXA9 |
| Diseases associated with this gene (DisGeNET). |
| Gene ID | Gene Symbol | Disease ID | Disease Name | Number of PMID | Source |
